In this episode, Scott and Tamara discuss more of the advantages of pharmacogenomics within long-term care settings. They present insights gleaned from their practical experiences, shedding light on both the positive outcomes and obstacles encountered in the implementation and utilization of pharmacogenomics.
Topics Discussed:
1) Cost avoidance/cost effectiveness of PGx in the elderly
2) Top genes seen in the long-term care space
3) Challenges/obstacles of PGx in long-term care
Hosts:
Scott Stewart PharmD - linkedin.com/in/scott-stewart-34973870
Tamara Ruggles PharmD BCGP - linkedin.com/in/tamara-ruggles-491882251
